EN
HI
Senores Pharmaceuticals share price chart
Senores Pharmaceuticals Share Key Metrics
Volume
1.55 L
Market Cap
6013.22 CR
LTQ@LTP
1@1305.70
ATP
1312.03
Var Margin
20.59 %
Circuit Range
1044.6-1566.8
Delivery %
40.94 %
Value
20.36 CR
ASM/GSM
No
Market Lot
1
Summary
SENORES stock price is ₹1305.7 as of 2 Aug, 2026. The stock intraday movement has stayed between ₹1293.60 and ₹1329.90, while Senores Pharmaceuticals share price 52 week high low is ₹632.05 & ₹1509.80.
In terms of trading activity, SENORES share price has recorded a volume of 1,55,205 shares. The Senores Pharmaceuticals has a market cap of ₹46053588. The stock’s Average Traded Price (ATP) stands at ₹1312.03, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1 @ ₹1305.70.
The Senores Pharmaceuticals upper circuit limit is ₹1566.80 & The Senores Pharmaceuticals lower circuit limit is ₹1044.60, with a Value of ₹20.36 CR. The Delivery Percentage for the day is 40.94%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Senores Pharmaceuticals Fundamentals
P/E Ratio
47.43
P/B Ratio
6.22
Div. Yield
0
Sector P/E
64.05
Sector P/B
3.2
Sec. Div. Yield
0.52
Senores Pharmaceuticals Resistance and Support
Pivot 1297.87
Resistance
First Resistance
1316.04
Second Resistance
1339.67
Third Resistance
1357.84
Support
First Support
1274.24
Second Support
1256.07
Third Support
1232.44
Senores Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Jul 31 2026 | 1298.9 | 1305.7 | 1.03% | 1329.9 | 1293.6 |
| Thu Jul 30 2026 | 1318.3 | 1292.4 | -1.96% | 1321.5 | 1279.69 |
| Wed Jul 29 2026 | 1339 | 1318.3 | -0.42% | 1344.5 | 1310 |
Senores Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-27 | Quarterly Results |
| 2026-05-14 | Audited Results |
| 2026-01-20 | Quarterly Results & Others |
| 2026-01-07 | Others |
| 2025-11-06 | Quarterly Results |
| 2025-07-23 | Quarterly Results & Others |
| 2025-05-15 | Audited Results |
| 2025-01-23 | Quarterly Results & Others |
Senores Pharmaceuticals News
Senores Pharmaceuticals Ltd - 544319 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On June 30, 2026
Senores Pharma filed its Q1 FY27 statement on IPO fund utilization, reporting an ongoing delay in deploying Rs.107 crore allocated for its Havix manufacturing facility. The company is seeking shareholder approval for variation in the object. Minor reallocations of unutilized funds were also reported across other objectives.
Jul 27 2026 17:40:58
Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Senores Pharma released its Q1 FY27 IPO fund utilization report, indicating a Rs. 65.02 crore re-allocation of funds from the Atlanta sterile injections facility project to other subsidiary capital expenditure needs. Delays in the Atlanta project are attributed to geo-political issues, requiring shareholder approval for the revised plan and extended timeline to Q4 FY28.
Jul 27 2026 17:32:10
Read More
Senores Pharmaceuticals Management
| Name | Position |
|---|---|
| Vinay Kumar Mishra | Company Secretary & Compliance Officer |
| Swapnil Jatinbhai Shah | Managing Director |
Senores Pharmaceuticals Similar Stocks
Nephrocare Health Services Ltd.
681.65
-1.45 (0.21%)
FDC Ltd.
409.80
2.35 (0.58%)
Kovai Medical Center & Hospital Ltd.
5910.00
-38.50 (0.65%)
Aarti Pharmalabs Ltd.
667.15
-7.15 (1.06%)
Innova Captab Ltd.
974.25
4.70 (0.48%)
Supriya Lifescience Ltd.
867.00
7.10 (0.83%)
Orchid Pharma Ltd.
986.55
-13.70 (1.37%)
Bliss GVS Pharma Ltd.
465.65
10.50 (2.31%)
RPG Life Sciences Ltd.
2768.20
-9.90 (0.36%)
Senores Pharmaceuticals FAQs
The Buying Price of Senores Pharmaceuticals share is 1305.7 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Senores Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Senores Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Senores Pharmaceuticals shares is 47.43. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Senores Pharmaceuticals shares is 6.22. Useful to assess the stock's value relative to its book value.
To assess Senores Pharmaceuticals’s valuation compare Sector P/E, P/B which are 64.05 & 3.2 with sector averages, along with growth rates and financial metrics.
The Market Cap of Senores Pharmaceuticals is 6013.22 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Senores Pharmaceuticals share price is 1509.80 & 632.05. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Senores Pharmaceuticals belongs to the Healthcare sector.
Open a FREE Demat Account in 5 Mins.
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
